bs-41408R [Primary Antibody]
SARS-CoV-2 Nucleocapsid Protein Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: SARS-CoV-2 N protein

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 1805293653

Source: Recombinant SARS-CoV-2 Nucleocapsid

Purification: Purified by Protein A.

Storage: Aqueous buffered solution containing 0.01M PBS(pH7.4) with 0.1% Proclin300.Store at -20°C for 12 months.

Size: 100ul

Concentration: ≥1 ug/ul

Applications: WB(1:500-1000)
ELISA(1:5000-10000)

Cross Reactive Species: Virus
SARS-CoV-2
(SARS-CoV-2 )

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Lane 1: SARS-CoV-2 N protein(Cat# bs-41408P) at 50ng; Lane 2: SARS-CoV-2 N protein(Cat# bs-41408P) at 25ng; Lane 3: SARS-CoV-2 N protein(Cat# bs-41408P) at 15ng; Lane 4: SARS-CoV-2 N protein(Cat# bs-41408P) at 10ng ; Lane 5: SARS-CoV-2 N protein(Cat# bs-41408P) at 5ng;Lane 6: SARS-CoV-2 N protein(Cat# bs-41408P) at 2.5ng probed with SARS-CoV-2 N protein Polyclonal Antibody, Unconjugated (bs-41408R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.


Lane 1: SARS-CoV N protein(Cat# bs-49002P) at 50ng; Lane 2: SARS-CoV N protein(Cat# bs-49002P) at 25ng; Lane 3: SARS-CoV N protein(Cat# bs-49002P) at 15ng; Lane 4: SARS-CoV N protein(Cat# bs-49002P) at 10ng ; Lane 5: SARS-CoV N protein(Cat# bs-49002P) at 5ng;Lane 6: SARS-CoV N protein(Cat# bs-49002P) at 2.5ng;Lane 7: SARS-CoV-2 N protein(Cat# bs-41408P) at 50ng; Lane 8: SARS-CoV-2 N protein(Cat# bs-41408P) at 25ng; Lane 9: SARS-CoV-2 N protein(Cat# bs-41408P) at 15ng; Lane 10: SARS-CoV-2 N protein(Cat# bs-41408P) at 10ng ; Lane 11: SARS-CoV-2 N protein(Cat# bs-41408P) at 5ng;Lane 12: SARS-CoV-2 N protein(Cat# bs-41408P) at 2.5ng probed with SARS-CoV-2 N protein Polyclonal Antibody, Unconjugated (bs-41408R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.